Press Releases

See our recent news and announcements below. If you have any questions or for media inquiries, please contact for assistance or see specified media contact details within each release.

Pyramid Biosciences Secures $28 Million in Funding to Accelerate Clinical Programs

Waltham, MA, August 31, 2020 – Pyramid Biosciences, Inc., a Boston-based biotechnology company developing new precision therapies focused on the modulation of cell surface receptors, today announced the close of $28 million USD in funding. The financing will accelerate the growth of Pyramid Biosciences’ programs focused on novel tropomyosin receptor kinase (TRK) modulators in oncology and dermatology disorders. [click to read more]